What type of study is this?

This is a Human Clinical Trial study (also classified as: RCT).

What question did this study set out to answer?

This trial aims to assess the effectiveness of patient-reported outcome monitoring on recovery in prostate cancer patients post-surgery.

February 23, 2026Open Access

Effectiveness of patient-reported outcome-based symptom monitoring after prostate cancer surgery: protocol for a multicenter, randomized controlled trial

Key Points

This trial aims to assess the effectiveness of patient-reported outcome monitoring on recovery in prostate cancer patients post-surgery.
Multicenter randomized controlled trial involving 144 prostate cancer patients.
Participants assigned to either PRO-based monitoring intervention or control group with standard care.
Symptom data collected with M.D. Anderson Symptom Inventory at various postoperative intervals.
Primary outcome is comparing number of symptom threshold events between groups using a t-test.
The study evaluates postoperative recovery improvement in the intervention group compared to control.
Patient-reported outcome management may enhance quality of life post-surgery.
The approach could influence standard care practices in symptom management for prostate cancer.

Abstract

Surgery remains a primary treatment modality for prostate cancer. However, patients often experience a substantial burden of postoperative symptoms, which can significantly delay recovery and negatively impact quality of life. Patient-reported outcome (PRO)-based symptom management has emerged as a promising approach to support patient-centered care. Despite its growing importance, there is a lack of clinical trial evidence evaluating early postoperative symptom management in prostate cancer patients. We propose a multicenter randomized controlled trial to assess the effectiveness of a PRO-based symptom monitoring program with threshold-triggered alerts and clinician responses in promoting postoperative recovery in this population. This study will enroll 144 patients with prostate cancer across three hospitals. Participants will be randomly assigned in a 1:1 ratio to either the intervention or control group. The intervention group will receive PRO-based symptom monitoring, whereby specialist clinicians will intervene when scores for target symptoms—pain, fatigue, disturbed sleep, drowsiness, and dry mouth—reach a predefined threshold (score ≥ 4). The control group will receive standard postoperative care without PRO-triggered alerts. Symptom data will be collected using the M.D. Anderson Symptom Inventory at baseline (3 days before surgery) and on postoperative days 1, 2, 3, 5, 7, 14, 28, 42, and 90. The primary outcome—the number of symptom threshold events—will be compared between groups using a t-test. This trial aims to investigate early-phase postoperative symptom management in patients undergoing prostate cancer surgery. Specifically, it will evaluate the efficacy and safety of a WeChat-based symptom management system in postoperative care. This trial was registered in the Chinese Clinical Trial Registry (ChiCTR2400082090) on 20 March 2024, and the registration details are available at https://www.chictr.org.cn/showproj.html?proj=214038

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Hu et al. (Sat,) studied this question.

synapsesocial.com/papers/699ba07072792ae9fd87012d https://doi.org/https://doi.org/10.1186/s13063-026-09569-8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper